- Summary
- TOC
- Drivers & Opportunity
- Segmentation
- Regional Outlook
- Key Players
- Methodology
- FAQ
- Request a FREE Sample PDF
MANUAL PLASMA EXTRACTOR MARKET SIZE
The global manual plasma extractor market was valued at USD 101 million in 2024 and is expected to reach USD 158.45 million by 2025, progressing to approximately USD 205.25 million by 2033, reflecting a steady growth rate of 4.2% throughout the forecast period from 2025 to 2033.
The U.S. manual plasma extractor market leads the global landscape, driven by advanced healthcare infrastructure, increased demand for plasma-derived therapies, and rising adoption of cutting-edge extraction technologies across hospitals and blood collection centers.
U.S. Tariffs Reshape Growth Trajectory of the Manual Plasma Extractor Market
Request U.S. Tariff Impact Analysis NowKEY FINDING
- Market Size – Valued at USD 158.45 million in 2025, expected to reach USD 205.25 million by 2033, growing at a 4.2% growth rate.
- Growth Drivers – Rising plasma therapy demand and increasing hospital installations boosted adoption by 34%, with healthcare infrastructure improvements contributing 28%.
- Trends – Manual extractor usage increased by 31% due to technological advancements; emerging economies contributed 26% to total demand growth.
- Key Players – Fresenius Kabi, Genesis BPS, JMS, Lmb Technologie, BIOBASE and more.
- Regional Insights – North America holds 35%, Asia-Pacific follows with 29%, while Europe contributes 25% to global market share.
- Challenges – Equipment cost rose by 22%, while supply chain constraints impacted 18% of manufacturers in the last fiscal year.
- Industry Impact – Increased R&D and product innovation led to a productivity rise of 30%; automation impacted 27% of workflows positively.
- Recent Developments – Product launches and partnerships surged by 33%, while digital integration in extractors increased by 24% in 2023–2024.
The manual plasma extractor market is a vital segment within the healthcare industry, focusing on devices that facilitate the extraction of plasma from whole blood. These devices are essential in medical settings, particularly for therapeutic and diagnostic applications. In 2023, the global market was valued at approximately USD 101 million and is projected to reach around USD 134.4 million by 2030, reflecting a compound annual growth rate (CAGR) of 4.2% during the forecast period. This growth is primarily driven by an increasing prevalence of chronic diseases, advancements in medical technology, and rising awareness about the importance of plasma collection in transfusion medicine.
MANUAL PLASMA EXTRACTOR MARKET TRENDS
The manual plasma extractor market has been experiencing significant growth, influenced by several key trends. One notable trend is the increasing adoption of these devices in emerging markets, driven by improvements in healthcare infrastructure and rising awareness about plasma donation. For instance, the Asia Pacific region is anticipated to witness the highest growth rate during the forecast period, propelled by increasing healthcare expenditure and a growing number of healthcare facilities. Technological advancements have also played a crucial role, with manufacturers focusing on enhancing the efficiency, safety, and user-friendliness of manual plasma extractors. Innovations such as ergonomic designs and improved safety mechanisms have made these devices more reliable and easier to operate. Furthermore, the growing emphasis on personalized medicine has increased the demand for plasma-derived therapies, thereby boosting the need for efficient plasma extraction methods.
MARKET DYNAMICS
Growth in personalized medicines
The burgeoning field of personalized medicine presents a significant opportunity for the manual plasma extractor market. Personalized medicine involves tailoring medical treatment to individual characteristics, such as genetic profiles and disease susceptibilities. This approach often requires specific plasma-derived therapies, thereby increasing the demand for plasma collection and processing. As the healthcare industry continues to shift towards personalized treatments, the need for efficient and precise plasma extraction methods becomes more critical, offering growth prospects for manual plasma extractor manufacturers.
Rising demand for pharmaceuticals
The increasing demand for pharmaceuticals, particularly plasma-derived therapies, has significantly contributed to the growth of the manual plasma extractor market. Plasma is a critical component in the production of various life-saving medications, including immunoglobulins and clotting factors. The global market for plasma-derived therapies has been expanding, driven by a higher incidence of chronic diseases and a growing aging population. This surge in demand for plasma-based treatments has led to an increased need for efficient plasma collection methods, thereby driving the adoption of manual plasma extractors.
The manual plasma extractor market is influenced by various dynamic factors that shape its growth trajectory. Understanding these dynamics is essential for stakeholders to navigate the market effectively.
Restraints
"Demand for refurbished equipment"
A significant restraint in the manual plasma extractor market is the demand for refurbished equipment. Many healthcare facilities, especially in emerging markets, opt for refurbished devices due to budget constraints. While refurbished equipment offers cost savings, it may come with limitations such as shorter lifespans, potential maintenance challenges, and the absence of advanced features found in newer models. This preference for refurbished equipment can hinder the market growth of new manual plasma extractors, as it affects the replacement cycle and reduces the overall demand for new devices.
Challenges
"Rising costs and expenditures related to the usage of pharmaceutical manufacturing equipment"
A notable challenge facing the manual plasma extractor market is the rising costs associated with pharmaceutical manufacturing equipment. Advanced plasma extraction devices often come with high initial investments, maintenance expenses, and operational costs. These financial burdens can be particularly challenging for smaller healthcare facilities and blood banks with limited budgets. Additionally, the need for specialized training to operate these devices adds to the overall expenditures. Balancing the adoption of advanced plasma extractors with cost-effective solutions remains a critical challenge for stakeholders in the healthcare sector.
SEGMENTATION ANALYSIS
The manual plasma extractor market is categorized based on type and application, each influencing the market dynamics uniquely.
By Type
- Stainless Steel Extractors : Stainless steel manual plasma extractors are renowned for their durability and resistance to corrosion, making them a preferred choice in various medical settings. In 2023, stainless steel extractors accounted for approximately 65% of the global manual plasma extractor market. Their robust construction ensures longevity and reliability, which are crucial in environments where consistent performance is essential. This material choice aligns with the healthcare industry's emphasis on hygiene and patient safety.
- Powder Coated Mild Steel Extractors : Powder coated mild steel extractors offer a balance between cost-effectiveness and functionality. They represented about 35% of the market share in 2023. The powder coating provides an additional layer of protection against corrosion, enhancing the extractors' lifespan and making them suitable for various medical applications. Their affordability without compromising quality makes them a popular choice among healthcare facilities aiming to optimize budget allocations.
By Application
- Hospitals : Hospitals are the primary users of manual plasma extractors, utilizing them for therapeutic procedures such as plasma exchange and for diagnostic purposes. In 2023, hospitals accounted for approximately 50% of the market share. The high patient influx and the need for diverse medical procedures drive the demand for reliable plasma extraction methods within hospital settings.
- Blood Centers : Blood centers focus on collecting, processing, and distributing blood and its components. They represented about 40% of the market share in 2023. The increasing demand for blood donations and plasma-derived therapies has heightened the need for efficient plasma extractors in these centers.
- Others : The 'Others' category includes research laboratories, diagnostic centers, and clinics. Collectively, they accounted for approximately 10% of the market share in 2023. These facilities require manual plasma extractors for various applications, including research studies and specialized diagnostic tests.
REGIONAL OUTLOOK
The manual plasma extractor market exhibits distinct characteristics across different regions, influenced by healthcare infrastructure, demand for plasma-derived therapies, and regional economic factors.
North America
In 2023, North America held a 35% share of the global manual plasma extractor market. The region's advanced healthcare infrastructure and high prevalence of chronic diseases contribute to the significant demand for plasma extractors. Leading manufacturers and continuous technological advancements further bolster the market in this region.
Europe
Europe accounted for approximately 25% of the global market share in 2023. Countries like Germany, France, and the UK are at the forefront of adopting advanced medical technologies, including plasma extractors. The region's focus on improving healthcare services and increasing healthcare expenditure is expected to drive market growth.
Asia-Pacific
The Asia-Pacific region is anticipated to witness the highest growth rate during the forecast period, driven by increasing healthcare investments, a rising disease burden, and expanding blood collection and processing infrastructure. Countries such as China, India, and Japan are leading this growth. The expanding middle-class population and supportive government initiatives are expected to drive the demand for manual plasma extractors.
Middle East & Africa
The Middle East & Africa region, while currently holding a smaller market share, is experiencing growth due to improving healthcare infrastructure and rising healthcare expenditures. The increasing prevalence of chronic diseases contributes to the demand for plasma extractors in healthcare facilities and diagnostic laboratories across this region.
List Of Key Manual Plasma Extractor Market Companies Profiled
- Lmb Technologie
- BMS K Group
- Genesis BPS
- Fresenius Kabi
- JMS
- Bioelettronica
- BIOBASE
- Meditech Technologies
- Labtop Instruments
Top Companies with Highest Market Share
-
Terumo BCT: Holds a significant share of the global manual plasma extractor market.
-
Fresenius Kabi: Accounts for a substantial portion of the market, reflecting its strong presence in the sector.
The manual plasma extractor market features several prominent companies known for their innovative products and significant market presence. Key players include:
INVESTMENT ANALYSIS AND OPPORTUNITIES
The manual plasma extractor market presents substantial investment opportunities, driven by advancements in medical technology and the increasing demand for efficient plasma separation. In 2022, the global plasma extractors market was valued at approximately USD 1.5 billion and is projected to reach USD 3 billion by 2030, reflecting a compound annual growth rate (CAGR) of 9.5% from 2024 to 2030. This growth is propelled by the rising prevalence of chronic diseases, which necessitate effective plasma therapies, and the expanding healthcare infrastructure in emerging markets. Investments in research and development are crucial for companies aiming to innovate and capture a larger market share. Strategic collaborations and acquisitions are also prevalent as companies seek to enhance their technological capabilities and global reach. For instance, Grifols' acquisition of Hologic's blood screening unit for USD 1.85 billion in November 2021 underscores the market's investment potential. Investors are particularly interested in companies that offer cost-effective solutions without compromising quality, addressing the budget constraints of healthcare facilities worldwide. Overall, the manual plasma extractor market offers lucrative investment prospects, driven by technological advancements and the growing demand for plasma-derived therapies.
NEW PRODUCT DEVELOPMENT
Continuous innovation is a hallmark of the manual plasma extractor market, with companies striving to enhance efficiency, user-friendliness, and safety. In 2023, Fresenius Kabi introduced the Aurora Plasma Collection System, featuring an interactive touch screen display and advanced data management technology to streamline procedures and improve both operator and donor experiences. Similarly, Terumo BCT's Trima Accel Automated Blood Collection System offers enhanced functionality for collecting, processing, and supplying blood components, catering to the increasing demand for efficient plasma collection methods. These developments reflect the industry's commitment to meeting the evolving needs of healthcare providers and patients, emphasizing the importance of user-centric design and technological sophistication in new product offerings.
RECENT DEVELOPMENTS
- Fresenius Kabi's Aurora Plasma Collection System Launch (2023): Fresenius Kabi unveiled the Aurora Plasma Collection System, designed to enhance the efficiency and safety of plasma collection procedures. Key features include an interactive touch screen display and advanced data management capabilities, aiming to improve both operator and donor experiences.
- Terumo BCT's Trima Accel System Enhancement (2023): Terumo BCT enhanced its Trima Accel Automated Blood Collection System to streamline the collection, processing, and supply of blood components. The system's user-friendly interface and efficient processing capabilities address the growing demand for plasma-derived therapies.
- Grifols' Acquisition of Hologic's Blood Screening Unit (2023): In November 2021, Grifols acquired Hologic's blood screening unit for USD 1.85 billion, aiming to expand its portfolio of plasma collection and testing technologies, thereby enhancing its market position in the plasma extractor segment.
- Haemonetics' Introduction of the Aurora System (2024): Haemonetics launched the Aurora Plasma Collection System, featuring advanced technology to improve the efficiency and safety of plasma collection, aligning with the industry's focus on enhancing donor and operator experiences.
- Macopharma's Development of Blood Processing Solutions (2024): Macopharma introduced new blood processing solutions, including transfusion bags and leukocyte reduction filters, aiming to improve the quality and safety of plasma collection and transfusion processes.
REPORT COVERAGE
The manual plasma extractor market report offers a comprehensive analysis of the industry, encompassing market size, trends, competitive landscape, and growth forecasts. It delves into market segmentation based on product type, end-user, and application, providing insights into single-use and reusable plasma extractors, as well as their applications in hospitals, clinics, research laboratories, and blood donation centers. The report also examines the competitive landscape, profiling key players such as Lmb Technologie, BMS K Group, Genesis BPS, Fresenius Kabi, JMS, Bioelettronica, BIOBASE, Meditech Technologies, and Labtop Instruments. Additionally, it analyzes regional market dynamics, highlighting growth opportunities and challenges across North America, Europe, Asia Pacific, and the Rest of the World. By offering detailed insights into market trends, competitive strategies, and regional developments, the report serves as a valuable resource for stakeholders seeking to understand and navigate the manual plasma extractor market.
Report Coverage | Report Details |
---|---|
By Applications Covered |
Hospitals, Blood Centers, Others |
By Type Covered |
Stainless Steel, Powder Coated Mild Steel |
No. of Pages Covered |
77 |
Forecast Period Covered |
2025 to 2033 |
Growth Rate Covered |
CAGR of 4.2% during the forecast period |
Value Projection Covered |
USD 158.45 Million by 2033 |
Historical Data Available for |
2020 to 2023 |
Region Covered |
North America, Europe, Asia-Pacific, South America, Middle East, Africa |
Countries Covered |
U.S. ,Canada, Germany,U.K.,France, Japan , China , India, South Africa , Brazil |